Article

Monitor PSA closely in testosterone therapy patients

Although there is no confirmed direct link between testosterone replacement therapy and prostate cancer, a recent study suggests that physicians treating middle-aged hypogonadal men with extrinsic testosterone should be more vigilant in monitoring these patients' PSA levels than they would be in monitoring average men of the same age.

Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
Yahir A. Santiago-Lastra, MD, answers a question during a Zoom video interview
© 2025 MJH Life Sciences

All rights reserved.